NCT07270835 2025-12-08
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 4 Recruiting
Clinical Trials
6 trialsNCT06956092 2025-05-02
Glofitamab
Zhengzhou University
Phase 4 Not yet recruiting
NCT05806580 2024-10-23
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital
Phase 4 Recruiting
NCT06609304 2024-10-15
axi-cel
Zhengzhou University
Phase 4 Recruiting
NCT05814848 2023-06-15
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
Changhai Hospital
Phase 4 Not yet recruiting
NCT02992834 2016-12-14
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
The First People's Hospital of Changzhou
Phase 4 Unknown